More than two decades after its application in children (1) , maintenance hemodialysis mains the mainstay of replacement therapy for the anemic child unable or unwilling to receive a transplant. More than 1000 children are being treated by hemodialysis in the United States, where of the 4000 patients with endstage renal disease about 45% are transplant recipients, over 30% are on hemodialysis, and less than 25% are undergoing peritoneal dialysis (2). In Europe likewise, according to 1983 European Dialysis and Transplant data, hospital hemodialysis accounted for 46% of children under 15 and 36% of children over 15, compared to only 9% and 2% respectively for continuous ambulatory peritoneal dialysis (3) . Yet only ten years ago CAPD looked so easy that it was expected to supplant hemodialysis. One of the reasons this has not happened is the persistently high rate of peritonitis -one episode per 6 patient months (3, 4) . The higher morbidity and trend toward mortality recorded in one of the pioneering C.A.P.D. centers when compared to hemodialysis (5) , would also suggest that a longer period of observation is needed before the role of C.A.P.D. can be fully determined.
In maintenence hemodialysis in children vascular access continues to be problematic. Arteriovenous shunts, such as the Buselmeier (6), are now seldom used, because of the risk of vessel occlusion and infection. In children weighing less than 15 kg or under the age of 5 years, a Thomas shunt (7) placed into the proximal femoral artery, or its adaptation into other proximal vessels (8) , remains a useful procedure. However, clotting of the shunt due to obstruction of the venous anastomosis by overgrowth of the intima is a major problem. Recently specially designed hemodialysis catheters such as the Hickman Catheter (9) have almost completely supplanted the use of shunts. Placed in the subclavian or the internal jugular vein, these catheters may be left in place for months and have enabled infants weighing about 6 kg. to receive hemodialysis for prolonged periods.
An arterio-venous fistula, using the radial artery and the cephalic vein (10) placed in the nondominant arm with an end to side anastomosis, is the commonest access for older children. In infants weighing between 5-10 kg a saphenous-loop fistula anastomosing the distal end The International Journal Of Artificial Organs / Vol. 9 no. 4, 1986/ p.p. 215-216 of the saphenous vein to the side of the femoral artery has also been used successfully (11) An alternative in small patients is the placement of a synthetic bovine or polytetrafluorethylene (P.T.F.E.) graft (12) anastomosed to femoral vessels in younger patients, and brachial or radial vessels in older children. Good flow rates are obtained with such grafts, but because of infection and thrombosis this should be used only when native vessels are unavailable.
The mortality from hemodialysis in major pediatric centers remains low. Actuarial survival at Children's Hospital in Boston (13) is 90% at 1 year. It is 92% at 1 year at the Downstate Medical Center in Brooklyn (14) . Four year actuarial survival for the Downstate center is 72% (14) and 74% for the E.D.T.A. registry (15) . Considerable morbidity, however, is reported in long term studies. Most children undergoing hemodialysis require blood transfusions every 3-4 weeks (14, 16) , and growth velocity percentiles decline with increasing duration of dialysis (17) . Despite optimal nutritional support, normalization of biochemical indices, and control of renal osteodystrophy, the growth rate is likely to continue to diminish on hemodialysis therapy. Deacceleration of growth is seen even in children who begin dialysis with height percentile exceeding 50% (14) .
Rehabilitation, if assessed by full time school attendance, is about 90% (14, 18) . Compared to adults, where rehabilitation is defined as full time employment, the results in children are better. Yet school attendance cannot be considered synonymous with school performance. Studies on the quality of life in children, comparable to those of Johnson et al in adults (19) , have yet to be conducted.
We conclude that pediatric hemodialysis is acceptable as a long term therapy even in small infants because mortality is low. Considerable morbidity in the form of hospitalization and neurologic, endocrinologic and gastrointestinal symptoms persist. This, coupled with the universal stunting of growth and the dislike children have of being tied to a machine, makes hemodialysis a less than optimal replacement therapy.
